Business
Pfizer’s coronavirus vaccine gets OK from FDA advisers in US – Sydney Morning Herald
The FDA is widely expected to authorise the vaccine, developed with German partner BioNTech SE, for emergency use in the United States within days.
Pfizer has asked that the two-dose vaccine be approved for use in people aged 16 to 85. Several advisory panel members discussed whether 16 and 17-year-olds should be included in the recommendation because the risk to these individuals is low, and the evidence in the trial was scant.
In the end, they voted on the question as put them by the FDA, which included 16 to 17-year-olds. The FDA typically follows the advice of its expert panels, but is not bound to do so.
The panel also discussed concerns…
-
Noosa News20 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News21 hours agoBrisbane-bound traffic diverted after pile-ups along Bruce Highway
-
Noosa News20 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General16 hours agoAustralian Catholics mourning death of Pope Francis